DUBLIN, Oct. 1, 2018 /PRNewswire/ --
The "Next Generation Sequencing - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.
The Global Next Generation Sequencing market is expected to grow at a CAGR of 18.7% during the forecast period.
Factors such as growing adoption of sequencing technologies in clinical applications and low cost DNA sequencing are likely to drive the market growth.
On the other side, accuracy and standardization issues and lack of skilled labour are inhibiting the market growth. However, rise in personalize medicine and cloud computing are likely to create more opportunities for this market during the forecast period.
North America is expected to surpass the other regions throughout the forecast period due to the support from various government bodies, like NHGRI (National Human Genome Research Institute, US) and fund research on the genome's structure, function, and role in health and disease.
Scope
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Key Topics Covered
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.5 Research Sources
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Futuristic Market Scenario
4 Porter's Five Forces Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Next-Generation Sequencing Market, By Type of Sequencing
5.1 Introduction
5.2 Whole Genome Sequencing
5.3 Targeted Resequencing
5.4 Whole Exome Sequencing
5.5 RNA Sequencing
5.6 CHIP Sequencing
5.7 De Novo Sequencing
5.8 Methyl Sequencing
5.9 Single-Molecule Real-Time Sequencing
5.10 Pre-sequencing
6 Global Next-Generation Sequencing Market, By Product
6.1 Introduction
6.2 Instruments
6.3 Reagents & Consumables
6.4 Services
6.5 Platforms
7 Global Next-Generation Sequencing Market, By Application
7.1 Introduction
7.2 Reproductive Health
7.3 Oncology
7.4 HLA Typing/Immune System Monitoring
7.5 Metagenomics, Epidemiology & Drug Development
7.6 Agrigenomics & Forensics
7.7 Consumer Genomics
7.8 Clinical Investigation
8 Global Next-Generation Sequencing Market, By End-User
8.1 Introduction
8.2 Pesticides
8.3 Hospitals
8.4 Academics
8.5 Biotech and Pharmaceutical Firms
8.6 Drug Discovery/Personalized Medicine
8.7 Genetic Screening
8.8 Diagnostics/Infectious Diseases
8.9 Agriculture and Animal Research
8.10 Other End Users
9 Global Next-Generation Sequencing Market, By Geography
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia Pacific
9.5 South America
9.6 Middle East & Africa
10 Key Developments
10.1 Acquisitions & Mergers
10.2 Agreements, Partnerships, Collaborations and Joint Ventures
10.3 Product Launch & Expansions
10.4 Other Activities
11 Company Profiling
11.1 Thermo Fisher Scientific Inc.
11.2 F. Hoffmann-La Roche AG
11.3 Illumina, Inc.
11.4 Beijing Genomics Institute
11.5 Qiagen N.V.
11.6 Pacific Biosciences of California, Inc.
11.7 Perkinelmer, Inc.
11.8 Agilent Technologies, Inc.
11.9 GATC Biotech AG
11.10 Oxford Nanopore Technologies, Ltd.
11.11 Macrogen, Inc.
11.12 Eurofins Scientific
11.13 Myriad Genetics
11.14 Bio-Rad Laboratories, Inc.
11.15 Pieriandx
11.16 Roche Holding AG
11.17 Genomatix GmbH
11.18 DNASTAR Inc.
11.19 Macrogen Inc.
11.20 Helicos BioSciences
For more information about this report visit https://www.researchandmarkets.com/research/ncm6cq/next_generation?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article